Metal organic frameworks (MOFs) are a growing class of crystalline hybrid porous materials with ultrahigh surface areas. They have shown some exciting applications in gas storage, separation, catalysis, sensing, and drug delivery. The area of research dealing with synthesis and applications of MOFs is progressing at an extraordinary pace, and it has been speculated that at least one article in every new issue of chemistry journals focuses on some aspect or application of MOFs (Long and Yaghi 2009) . MOFs are synthesized with highly tunable crystal sizes ranging from few nanometers to micrometers. MOFs with dimensions in micrometers or above (bulk MOFs) are widely used for the applications like gas storage, separation and catalysis. However, some applications of MOFs such as drug delivery or sensing require miniaturization of MOFs and it leads to synthesis of new class that is known as nanoscale MOFs. Nanoscale MOFs cannot be strictly limited to MOFs with dimensions in between 1 and 100 nm (like general nanomaterials) as MOFs having sizes up to 500 nm have also been reported as nanoscale MOFs. Due to integration of the intrinsic properties of the porous materials with nanostructures, nanoscale MOFs are expected to show better performance than their bulk counterparts (Giménez-Marqués et al. 2015) . Such nanoscale MOFs are administered for some biomedical applications where particles with very small dimensions are required. For example, parenteral route requires particles with size less than 200 nm to freely circulate in smallest capillaries (Horcajada et al. 2012) .
The synthesis and applications of nanomaterials in different fields is a hot subject of academic and industrial research. These materials possess unique and extraordinary features compared to bulk materials. These features include extremely small size, high surface area, most of the time good mobility, high reactivity and penetration ability and so on. However, safety of these materials for the human and environment is a matter of serious concern. Despite the fact, aforementioned features make nanomaterials highly useful for number of applications, but on the other hand, these features are thought to be major contributors to the toxicity of nanomaterials (Sajid et al. 2015b) . Hence, the next challenge is related to regularize the safe limits of nanomaterials for environment and occupational safety. In addition, the development of sensitive and efficient analytical methods for monitoring of nanomaterials in environment is itself a challenge. It is the reason that many research groups of analytical chemists are now working toward the determination of nanomaterials in environment (Rodrigues et al. 2016; Majedi and Lee 2016) . Nanoscale MOFs are relatively new addition in the world of nanomaterials, and therefore, very little is known about safety of these materials for environment and human health.
The toxicity of either bulk or nanoscale MOFs is not well established. We know that size of the material is an important parameter for toxicological considerations. Size of material determines its cellular uptake, biodistribution, translocation, and excretion from the body. As the size of the material decreases, its surface to volume ratio increases, and in turn, the material becomes more reactive. It is now reported by many studies that cytotoxicity and translocation of NPs is highly dependent on the size (Sajid et al. 2015b) . Hence, nanoscale MOFs should be preferably evaluated for their toxicity to human and other living organisms compared to bulk MOFs. However, in case of MOFs, toxicity cannot only be associated with the size of materials because the nature of materials used for synthesis is another premier factor. The parameters like cellular uptake, biodistribution, translocation, and excretion from the body are highly affected by size, degradation rate, shape, and nature of functionalized surface. Thus, all types of metals, organic ligands, linkers, and functionalized materials should be evaluated while performing toxicity studies.
Stability of nanomaterial is another parameter that dictates about its toxicity. The solubility and degradation of MOF in a given biological system will depend upon composition of MOF and pH, ionic strength and peristaltic movements of biological system. At physiological conditions, most of the organic and inorganic nanomaterials will not be completely soluble (or will take longer time to degrade) and this leads to accumulation that forms the basis of in vivo toxicity. In case of metallic nanomaterials, the concentration of metal will increase in the cells which may lead to high stress in the cells. Literature of MOFs reveals that most of the studies talk about thermally and chemically stable MOFs. MOFs which are stable up to 500°C have been reported (Colombo et al. 2011 ). The question is how these stable materials will behave in the biological systems, although such stable materials are not directly applied for biomedicine but they may enter into biological systems by inhalation, ingestion, or dermal contact. In other case, if the MOFs are not so stable, then leaching of the metals inside the cellular apartments may lead toxic accumulations but this will be determined by the nature of the metal and its concentration. In addition to the metals, the toxicity studies should also be performed for organic linkers. Of course, for biomedical applications, the MOFs with metals having acceptable toxicity will be considered but still other parameters such as effect of repetitive dose, accumulation, and exertion patterns should be evaluated. Therefore, prior to utilization of such MOFs in biomedicine or other related applications, it will be highly important to determine their fate inside the biological systems.
In the drug delivery applications, non-toxic drug carriers with nanodimensions are desired. However, most of the existing materials either show poor drug loading or poor drug releasing. MOFs are attractive materials because of their tunable structures and porosities which in turn allows better drug loading and releasing. Non-toxic iron (III) based MOFs were used as nanocarriers for drugs against cancers and AIDs (Horcajada et al. 2010) . Although these applications are quite encouraging but the available data about the toxicity of MOFs is highly scarce. Thus, in vitro and in vivo toxicological assays need to be performed in order to assess hazards of nanoscale MOFs. In vitro toxicity assays are actually rapid and low cost tests that can provide initial toxicity data about any kind of emerging toxic materials. These assays are highly suited for high throughput screening. They are helpful in understanding mechanism of toxicity and the way of cellular interaction of nanomaterials. However, the results of in vitro studies may differ largely from in vivo studies. Therefore, one needs to be very careful while extrapolating from in vitro to in vivo considerations.
Very limited literature is available on in vitro and in vivo toxicity of nanoscale MOFs. The existing literature is not sufficient to conclude about the toxicity of the MOFs. In addition, toxicity assays have been performed using different cell lines and it makes comparison of obtained results much more difficult. Moreover, some contradictory statements are also available. For example, nanoZIF-8 (200 nm) was evaluated against three human cell lines (mucoepidermoid carcinoma of lung , colorectal adenocarcinoma , and promyelocytic leukemia ) and it was found that nanoZIF does not show any toxicity even at the highest tested concentration (109 μM) (Vasconcelos et al. 2012) . However, in another report nanoZIF-8 (90 nm) showed some cytotoxicity to HeLa and J774 cell lines, the IC 50 values of 436 and 109 μM were observed against HeLa and J774, respectively (Tamames-Tabar et al. 2014) . In another work, uncoated nanoscale MOFs were assessed by in vitro toxicity to HepG2 and MCF7 cells and in vivo against zebrafish embryos. This study revealed that toxicity of nanoscale MOFs is dependent on the nature of the MOF and solubility of the contents in the tested medium. A strong correlation was observed between in vitro and in vivo toxicity. Toxicity was mainly attributed to leached metal ions. They concluded that other factors such as formation of new species upon degradation, nature of crystals (e.g., size, shape, charge, etc.) may also contribute to toxicity of nanoscale MOFs (Ruyra et al. 2015) . There are many other parameters that may contribute toward toxicity of nanoscale MOFs, e.g., reactivity, solubility, mobility, penetration ability, nature of functionalized material, type of metal and organic precursors.
Only few studies talk about in vivo toxicity of nanoscale MOFs. In order to understand distribution, metabolism and excretion, three different Fe(III) carboxylate nanoMOFs were intravenously injected in rats at high doses for acute in vivo toxicity assays. This study revealed that all tested MOFs showed low acute toxicity and rapidly sequestered by liver and spleen and then further biodegraded and eliminated in urine or feces without metabolization and significant toxicity (Baati et al. 2013) . In another report, the in vivo toxicity of mechanically downsized Gd(III)-pDBI (pDBI =1,4-bis(5-carboxy-1H-benzimidazole-2-yl)benzene) NPs was determined by intravenous administration of doses between 0.05 and 0.15 mg kg −1 using a murine model. This study showed lack of severe toxicity. Non-specific but minor alterations were found in the liver associated with accumulation of GdpDBI NPs (Kundu et al. 2014) . As far as the human exposure to MOFs is concerned, occupational exposure may occur during synthesis, characterization, packing, transportation, and applications of these materials. The major routes of exposure may include dermal penetration, inhalation, and ingestion. Occupational exposures can be minimized to a certain extent by adopting good lab practices that include use of special personal safety equipment and proper control of working environment. It is not only the working environment that should be regularly monitored but also the working personnel should be periodically checked for potential health related risks. The exposure of general population and behavior of MOFs in outdoor environment is also a subject that has not been investigated yet. Similarly, the presence of nanoscale MOFs in air, soil, and aquatic environments and their subsequent effects on living organisms are not studied so far. The materials which can stay up to temperature of 500°C or above and have unprecedented chemical stability, how they will degrade in natural environment or where they will be disposed of? All these questions need to be answered through additional research studies focusing on the mechanisms of degradation under ambient conditions. The question of allowable limits of nanoscale MOFs in indoor or outdoor environments could be addressed after establishing their toxicity.
It can be safely concluded that more comprehensive studies on the possible environmental and health risks of these emerging materials must be performed before they can be employed for practical applications. The toxicity of MOFs should be studied in a systematic way to ensure human health and environment safety. National and International environment protection agencies should develop a systematic way of evaluating all the developed MOFs for their environmental and health impact. In this way, we can reach a stage, where we can safely arrange some MOFs based on their toxicity and further regulations can be established. However, this all should not be delayed to the point that one may see MOFs standing with POPs (Sajid et al. 2016) , EDCs (Sajid et al. 2015a) , or other emerging pollutants (USEPA) from the perspective of their toxicity and impact on human health and environment.
